Denise Laspina is an associate in the Washington, D.C. office of Latham & Watkins.
Ms. Laspina assists clients on a broad range of matters relating to intellectual property disputes within the life sciences and other technical industries. Notably, Ms. Laspina has assisted with preparing invalidity defenses in Hatch-Waxman litigation and research support regarding the FDA’s Orange Book.
Ms. Laspina maintains an active pro bono practice, most recently representing survivors of gender-based violence and victims of human trafficking and other crimes.
Before joining Latham, Ms. Laspina spent time researching personalized medicine for cancer patients and studying neurodegeneration. She served as an editor of the Michigan Law Review and organized fundraisers for public interest Latinx law students. During her 1L internship, Ms. Laspina worked in-house at AbbVie on a range of patent and FDA focused matters.